HH is one of the sole genetic diseases benefiting from a simple and efficient treatment when implemented early. This treatment relies on regular phlebotomies. Without its early implementation, this disease has a poor prognosis and can progress toward irreversible damage, such as hepatocarcinoma or heart failures.